Searching map area
Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial TRAPEZE trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747)
Join to rate
Ratings
0
Nobody has rated this yet. Be the first!
Lists
0
Join to rate
Instance of
Scholarly article
Subject
Zoledronic acid
Docetaxel
Wikidata